trending Market Intelligence /marketintelligence/en/news-insights/trending/tua5ngrhldvnbp8lzxzlda2 content esgSubNav
In This List

Revance CFO/chief business officer resigns

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Revance CFO/chief business officer resigns

Revance Therapeutics Inc. said Lauren Silvernail resigned as the company's chief business officer and CFO to pursue an opportunity at an Orange County, Calif.-based aesthetics company.

The Newark, Calif.-based biotechnology company said certain members of management and its existing finance team will assume the duties and responsibilities of the office on an interim basis.

The company will begin a search for a new CFO.